Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The popularity of Low-Titer O Whole Blood (LTOWB) for treating trauma patients requires that donor centers and transfusion services make decisions on what titer testing capabilities to institute and an appropriate titer level threshold. This study compared the titer results determined by four methods to find a rate of agreement.

Study Design And Methods: Isohemagglutinin titers were tested on 300 plasma samples utilizing various methods, each determining IgM antibody levels by direct hemagglutination with A1 and B reference cells. The methods used were the Beckman Coulter's PK7300, Immucor's NEO Iris microplate technology, Ortho Clinical Diagnostics (OCD) Vision, and manual titrations.

Results: Only 42.7% of the samples tested showed agreement across all methods on ABO isohemaglutinin titer levels and only 32.5% demonstrated "High titer" agreement. Sample agreement was close to 90% if the Immucor method was excluded. At a <1:256 titer level threshold, the pass rate was 94.3% for Immucor, 89.7% for the PK7300, 87.3% for manual testing, and 75.7% for OCD's gel method. Sensitivity and specificity rates at a ± 1 titer level were respectively 100% and 95.4% for OCD's gel, 73.7% and 100% for Immucor, and 100% and 99.6% for the PK7300. Overall method accuracy was 91.7% for Immucor, 90.3% for the PK7300, and 86.7% for OCD's gel method as compared to manual titration.

Conclusion: All three automated methods perform comparably to the manual method at a ± 1 titer tolerance level. Based on these comparisons, a titer level of <1:256 would maximize LTOWB production regardless of the method used.

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.17953DOI Listing

Publication Analysis

Top Keywords

low-titer blood
8
methods
5
comparison manual
4
manual titrations
4
titrations automated
4
automated microplate
4
microplate gel
4
gel titration
4
titration assays
4
assays screening
4

Similar Publications

Clotting factor concentrate (CFC), used to treat and prevent bleeding in hemophilia, is rendered ineffective if clotting factor neutralizing antibodies (inhibitors) develop. Inhibitors occur most often in children, early in treatment. The American Thrombosis and Hemostasis Network (ATHN) 8: US Cohort Study of Previously Untreated Patients (PUPs) with Congenital Hemophilia, conducted in children born in 2010 to 2020 with severe or moderate hemophilia, was designed to determine the percentage of participants who developed a confirmed, clinically significant inhibitor within the first 50 CFC exposure days (EDs).

View Article and Find Full Text PDF

Background: The use of low-titer O whole blood (LTOWB) is requested in the treatment of major bleeding, initially used in military medicine but now increasingly utilized in civilian prehospital care. The advantage is the administration of a balanced transfusion, red blood cells, coagulation factors, and platelets, in one bag. The challenges are the availability of LTOWB and difficulties in predicting the need in major bleeding, leading to the risk of wastage.

View Article and Find Full Text PDF

Background: Myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG) positivity has been reported in some people with multiple sclerosis (pwMS), posing a diagnostic challenge. However, most studies have been conducted in predominantly Caucasian populations. We aimed to determine the frequency of MOG-IgG in a large, predominantly Asian MS cohort using a validated MOG-IgG assay.

View Article and Find Full Text PDF

Background: Prehospital blood transfusions are necessary in certain situations that involve significant bleeding to prevent fatality.

Study Design And Methods: Members of the AABB Donor and Blood Component Management Prehospital working group collaborated to provide a consensus review of best practices in the implementation of a prehospital transfusion program.

Results: Several logistic paradigms exist in terms of how blood products are provided to emergency medical services (EMS).

View Article and Find Full Text PDF

This case report describes the management of a middle-aged woman with abnormal uterine bleeding who developed Anti-Jk and Anti-M antibodies following multiple transfusions, illustrating the challenges in transfusion medicine. Despite initial negative antibody screening, repeat testing post-transfusion revealed these clinically significant antibodies, demonstrating the dynamic nature of alloimmunization. The case highlights the importance of the MNS and Kidd blood group systems in transfusion reactions, particularly the risk of delayed hemolysis with anti-Jk antibodies.

View Article and Find Full Text PDF